Sign In
Buy MESO
$14.52
+0 (+0%)
At Close: Jun 03, 2026
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether
FDA Expediting Accelerated Development of Novel Therapies for COVID-19
12:00pm, Tuesday, 28'th Apr 2020
The U.S. Federal government is working closely with companies and researchers to find treatments and vaccines to overcome the global health crisis. The FDA has been cutting red tape and has launched n
Can Mesoblast’s COVID-19 Treatment Increase Survival Rate? Analyst Dives In
10:25pm, Monday, 27'th Apr 2020
Mesoblast's (MESO) shares are cooling off today. After skyrocketing 140% on Friday, the Australian biotech fell 25% today.The lift off came following the release of strong preliminary data concerning
Shares of Mesoblast Tumbled Over 20% Today After Doubling Last Week
08:16pm, Monday, 27'th Apr 2020
The Australian stem-cell therapy developer presented promising data for COVID-19 patients days ago, but investors took some gains off the table today.
Inovio Pharmaceuticals, Mesoblast, and Moderna: Are These Red-Hot Biotech Stocks Still a Buy?
02:00pm, Monday, 27'th Apr 2020
The COVID-19 pandemic has been a major catalyst for these three biotech stocks.
81 Biggest Movers From Friday
09:33am, Monday, 27'th Apr 2020
Gainers
Mesoblast Limited (NASDAQ: MESO) shares climbed 139.5% to close at $15.45 on Friday after the company reported 10 out of 12 patients with ventilator-dependent...
Mid-Afternoon Market Update: Dow Rises 150 Points; Pluristem Therapeutics Shares Spike Higher
06:38pm, Friday, 24'th Apr 2020
Toward the end of trading Friday, the Dow traded up 0.66% to 23,670 while the NASDAQ rose 1.16% to 8,593.43. The S&P also rose, gaining 0.96% to 2,824.71.
The U.S. is the...
Afternoon Market Stats in 5 Minutes
04:23pm, Friday, 24'th Apr 2020
Movers Indices • S&P 500 ETF (NYSE:SPY) rose 0.10% to $279.30.• Nasdaq ETF (NASDAQ:QQQ) increased 0.17% to $210.88.• Dow Jones Industrial Average ETF (NYSE:DIA) fell 0.20% to $234.63.• FTSE/Xi
54 Stocks Moving In Friday's Mid-Day Session
04:22pm, Friday, 24'th Apr 2020
Gainers
Mesoblast Limited (NASDAQ: MESO) jumped 134.8% to $15.14 after the company reported 10 out of 12 patients with ventilator-dependent coronavirus infection survived...
Mid-Day Market Update: Limelight Networks Falls Following Q1 Earnings; Mesoblast Shares Surge
04:00pm, Friday, 24'th Apr 2020
Midway through trading Friday, the Dow traded down 0.14% to 23481.83 while the NASDAQ rose 0.13% to 8505.65. The S&P also rose, gaining 0.07% to 2,799.73.
The U.S. is the...
Stocks That Hit 52-Week Highs On Friday
02:33pm, Friday, 24'th Apr 2020
During Friday's morning session, 28 stocks hit new 52-week highs.
Noteworthy Mentions:
The largest company by market cap to set a new 52-week high was Eli Lilly (...
Mid-Morning Market Update: Markets Mostly Flat; Verizon Profit Tops Estimates
02:15pm, Friday, 24'th Apr 2020
Following the market opening Friday, the Dow traded up 0.05% to 23527.17 while the NASDAQ fell 0.09% to 8487.46. The S&P also rose, gaining 0.05% to 2,799.17.
The U.S. is the...
CHK, BYND among premarket gainers
01:15pm, Friday, 24'th Apr 2020
Mesoblast (NASDAQ:MESO) +119% as cell therapy shows significant benefit in COVID-19 patients.Medigus (NASDAQ:MDGS) +73% on COVID-19 plan.Pluristem Therapeutics (NASDAQ:PSTI) +20% on €50 capital r
32 Stocks Moving in Friday's Pre-Market Session
11:11am, Friday, 24'th Apr 2020
Gainers
Abraxas Petroleum Corporation (NASDAQ: AXAS) shares rose 63.8% to $0.475 in pre-market trading after jumping 123% on Thursday.
FTS International, Inc. (NASDAQ: FTSI)...
Key points: 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated with two.
